Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michal Shteinberg

Showing results (81-90 of 143) with videos related to

Pageof 15
Sort By:
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 24, 2016
Changes of CFTR functional measurements and clinical improvements in cystic fibrosis patients with non p.Gly551Asp gating mutations treated with ivacaftorMyriam Mesbahi, Michal Shteinberg, Michael Wilschanski, et al.
The European Respiratory Journal|December 16, 2017
Standardised classification of the aetiology of bronchiectasis using an objective algorithmDavid Araújo, Michal Shteinberg, Stefano Aliberti, et al.
Respiratory Medicine|June 5, 2026
PULMONARY EXACERBATIONS IN CYSTIC FIBROSIS AFTER FATHERHOOD WITH AND WITHOUT CFTR MODULATORSMalena Cohen-Cymberknoh, Shavit Malca Hadad, Michal Shteinberg, et al.
Chest|August 13, 2023
Risk of SARS-CoV-2 Infection and Disease Severity Among People With Bronchiectasis: Analysis of Three Population RegistriesMichal Shteinberg, Oriol Sibila, Nili Stein, et al.
ERJ Open Research|July 19, 2023
A Phase 2 randomised study to establish efficacy, safety and dosing of a novel oral cathepsin C inhibitor, BI 1291583, in adults with bronchiectasis: AirleafJames D Chalmers, Abhya Gupta, Sanjay H Chotirmall, et al.
ERJ Open Research|February 22, 2021
What is important for people with nontuberculous mycobacterial disease? An EMBARC-ELF patient surveyMichal Shteinberg, Jeanette Boyd, Stefano Aliberti, et al.
The European Respiratory Journal|October 28, 2024
Targeting neutrophil serine proteases in bronchiectasisJames D Chalmers, Marcus A Mall, Sanjay H Chotirmall, et al.
Iscience|May 6, 2022
Calcium carbonate mineralization is essential for biofilm formation and lung colonizationMalena Cohen-Cymberknoh, Dror Kolodkin-Gal, Alona Keren-Paz, et al.
ERJ Open Research|October 29, 2025
The response of rare CFTR mutations to specific modulator combinationsNoemie Stanleigh, Michal Gur, Michal Shteinberg, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 17, 2026
Treatment outcomes of Mycobacterium simiae pulmonary disease: a retrospective multicenter cohort studyRonza Najjar-Debbiny, Raya Cohen, Anat Arbel, et al.
Pageof 15

Showing results (81-90 of 143) with videos related to

Sort By:
Pageof 15
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 24, 2016
Changes of CFTR functional measurements and clinical improvements in cystic fibrosis patients with non p.Gly551Asp gating mutations treated with ivacaftorMyriam Mesbahi, Michal Shteinberg, Michael Wilschanski, et al.
The European Respiratory Journal|December 16, 2017
Standardised classification of the aetiology of bronchiectasis using an objective algorithmDavid Araújo, Michal Shteinberg, Stefano Aliberti, et al.
Respiratory Medicine|June 5, 2026
PULMONARY EXACERBATIONS IN CYSTIC FIBROSIS AFTER FATHERHOOD WITH AND WITHOUT CFTR MODULATORSMalena Cohen-Cymberknoh, Shavit Malca Hadad, Michal Shteinberg, et al.
Chest|August 13, 2023
Risk of SARS-CoV-2 Infection and Disease Severity Among People With Bronchiectasis: Analysis of Three Population RegistriesMichal Shteinberg, Oriol Sibila, Nili Stein, et al.
ERJ Open Research|July 19, 2023
A Phase 2 randomised study to establish efficacy, safety and dosing of a novel oral cathepsin C inhibitor, BI 1291583, in adults with bronchiectasis: AirleafJames D Chalmers, Abhya Gupta, Sanjay H Chotirmall, et al.
ERJ Open Research|February 22, 2021
What is important for people with nontuberculous mycobacterial disease? An EMBARC-ELF patient surveyMichal Shteinberg, Jeanette Boyd, Stefano Aliberti, et al.
The European Respiratory Journal|October 28, 2024
Targeting neutrophil serine proteases in bronchiectasisJames D Chalmers, Marcus A Mall, Sanjay H Chotirmall, et al.
Iscience|May 6, 2022
Calcium carbonate mineralization is essential for biofilm formation and lung colonizationMalena Cohen-Cymberknoh, Dror Kolodkin-Gal, Alona Keren-Paz, et al.
ERJ Open Research|October 29, 2025
The response of rare CFTR mutations to specific modulator combinationsNoemie Stanleigh, Michal Gur, Michal Shteinberg, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|March 17, 2026
Treatment outcomes of Mycobacterium simiae pulmonary disease: a retrospective multicenter cohort studyRonza Najjar-Debbiny, Raya Cohen, Anat Arbel, et al.
Pageof 15